Stock Taper 
DGX
$242.76
▼ DOWN 0.76% (-1.85)
KEY STATISTICS
Market Cap$26.79 B
52w High$247.19
52w Low$171.18
Dividend Yield1.44%
FrequencyQuarterly
P/E23.94
Volume639.93K
Shares Out.110.37M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
James E. Davis
COMPENSATION 2026
Salary$1,250,000
Stock Awards$8,762,861
Incentive Plan Pay$2,205,844
All Other Comp.$279,901
Total$15,498,479
ABOUT
SECTOR
Healthcare
WENT PUBLIC
December 17, 1996
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
51,500
PRICE TARGET
Target High$260.00
Target Low$225.00
Target Median$247.50
Target Consensus$244.50
UPCOMING EARNINGS
DateOct 20, 2026
DayTuesday
Rev. Est.$3.04B
OCT
20
TUE
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2005-06-21 | Forward | 2:1 |
| 2001-06-01 | Forward | 2:1 |
PRICE
$242.76 ▼ DOWN 0.76% (−$1.85)About Quest Diagnostics Incorporated
https://www.questdiagnostics.com ↗Quest Diagnostics provides diagnostic testing, information, and services across the U.S. and internationally for patients, clinicians, and organizations through labs, centers, and IT solutions.
INDUSTRY
Medical - Diagnostics & Research
A PRODUCT QUEST DIAGNOSTICS INCORPORATED IS KNOWN FOR
Genetic Insights
Quest's at-home genetic test analyzes 36 genes to assess inherited risks for various health conditions, offering personalized reports and genetic counseling as part of its direct-to-consumer strategy.
Revenue by Products
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Diagnostic Information Services Business | $2.75B | $2.74B ▼ | $2.83B ▲ | $2.98B ▲ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
886
LISTED HERE
26
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
72.11%
HOLDERS
1,614
TOP 12 OF 1,614 · RANKED BY POSITION SIZE
Vanguard Group Inc
Blackrock Inc.
Blackrock, Inc.
Abrdn Inc.
Price T Rowe Associates Inc /Md/
State Street Corp
Boston Partners
Blackrock Advisors LLC
Blackrock Institutional Trust Company, N.A.
Jpmorgan Chase & Co
Blackrock Fund Advisors
Geode Capital Management, LLC
RATINGS SNAPSHOT
Overall rating: B
Discounted Cash Flow4
Return On Equity4
Return On Assets4
Debt To Equity1
Price To Earnings2
Price To Book2
Overall Score3
TRADES BY CONGRESS
HOUSE TRADES
Julie Johnson
Sale
2025-11-03
Julia Letlow
Sale (Full)
2025-07-24
Carol Devine Miller
Sale (Full)
2025-03-10
Gilbert Cisneros
Sale
2025-01-24
INSIDER TRADES
★
OFFICER: SVP & CHIEF COMMERCIAL OFFICER
DELANEY MARK E
Sale · 1.6K shares
2026-07-28
★
OFFICER: SVP, CLINICAL SOLUTIONS
KUPPUSAMY KARTHIK
Purchase · 37 shares
2026-07-22
★
OFFICER: SVP & CHIEF COMMERCIAL OFFICER
DELANEY MARK E
Purchase · 34 shares
2026-07-22
★
DIRECTOR
Gregg Vicky B
Purchase · 72 shares
2026-07-22
MOST RECENT ANALYST GRADES
GRADE SUMMARY
NEUTRAL 5
OUTPERFORM 2
OVERWEIGHT 1
HOLD 1
IN LINE 1
BUY 1
11 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 ILMN | $215.59 | COMPARE |
 WAT | $414.69 | COMPARE |
 LH | $335.11 | COMPARE |
 INCY | $124.37 | COMPARE |
 WST | $337.47 | COMPARE |
 UTHR | $515.46 | COMPARE |
 THC | $266.80 | COMPARE |
 ZBH | $100.91 | COMPARE |